Citadel Advisors’s SRAX, Inc. Class A Common Stock SRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-38,200
Closed -$58.4K 16253
2022
Q4
$58.4K Buy
38,200
+13,300
+53% +$21.4K ﹤0.01% 11943
2022
Q3
$43K Sell
24,900
-25,100
-50% -$58.7K ﹤0.01% 11739
2022
Q2
$166K Sell
50,000
-59,600
-54% -$220K ﹤0.01% 10882
2022
Q1
$529K Sell
109,600
-18,300
-14% -$86.6K ﹤0.01% 9258
2021
Q4
$574K Sell
127,900
-7,100
-5% -$37.3K ﹤0.01% 9364
2021
Q3
$721K Sell
135,000
-68,800
-34% -$330K ﹤0.01% 8992
2021
Q2
$1.11M Buy
203,800
+133,700
+191% +$643K ﹤0.01% 8097
2021
Q1
$332K Buy
70,100
+54,100
+338% +$226K ﹤0.01% 10607
2020
Q4
$50K Buy
+16,000
New +$42.6K ﹤0.01% 10568

Other funds holding SRAX

Citadel Advisors's SRAX Position: Q1 2023 in Review

Citadel Advisors sold out of SRAX, Inc. Class A Common Stock (SRAX) in Q1 2023, closing a stake of 397 shares — an estimated $607 sold.

Citadel Advisors first reported a position in SRAX in Q3 2017 and held it in 9 quarters. The position peaked at $431K in Q4 2021. 5 funds tracked by Wall St. Rank hold SRAX as of Q1 2023.

  • Citadel Advisors reported no remaining SRAX, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 397 SRAX, Inc. Class A Common Stock shares in Q1 2023, an estimated $607.
  • Citadel Advisors first reported a position in SRAX, Inc. Class A Common Stock in Q3 2017 and held it in 9 quarters.
  • Citadel Advisors's SRAX, Inc. Class A Common Stock position peaked at $431K in Q4 2021.
  • 5 funds tracked by Wall St. Rank held SRAX, Inc. Class A Common Stock as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.